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Gingival recession treatment 
with concentrated growth factor 
membrane: a comparative clinical trial
Objective: This clinical trial sought to evaluate the clinical effectiveness 
of concentrated growth factor (CGF) and compare it with connective tissue 
graft (CTG) with coronally advanced flap (CAF) in the treatment of Miller 
Class I gingival recessions (GR). Methodology: This split-mouth study 
included 74 Miller Class I isolated (24 teeth) or multiple (50 teeth) GRs in 23 
jaws of 19 patients. GRs were randomly treated using CGF (test group: 37 
teeth; 12 teeth in isolated GRs, 25 teeth in multiple GRs) or CTG with CAF 
(control group: 37 teeth;12 teeth isolated GRs, 25 teeth in multiple GRs). 
Clinical variables, plaque index (PI), gingival index (GI), probing depth (PD), 
recession depth (RD), recession width (RW), clinical attachment level (CAL), 
keratinized tissue thickness (KTT), keratinized tissue width (KTW), and root 
coverage (RC) were assessed at the baseline as well as at three and six 
months post-surgery. Healing index (HI) were obtained in the second and third 
weeks post-surgery. Postoperative pain was assessed for the first seven days 
using a horizontal visual analog scale (VAS). Results: No significant change 
was observed in PI, GI, or PD values in either the intergroup or the intragroup 
comparisons. A statistically significant decrease was observed in CAL, RD, 
and RW, and KTT increased in all groups at three and six months compared 
with the baseline. The control group had greater increases in KTW, KTT, and 
RC at three and six months. No significant difference was found in CAL or RD 
at the third and sixth months between the two groups. Healing was found to 
be similar for both groups in the second and third weeks post-surgery. The 
VAS values in the control group were higher than in the test group, especially 
at the second, fourth, fifth, and seventh days postoperatively. Conclusions: 
CTG is superior to CGF with CAF for increasing KTT, KTW, and RC. CGF may 
be preferable due to decreased postoperative pain.
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Introduction
Gingival recession (GR) is defined as the change in 
the position of the marginal part of the gums apically 
to the cement–enamel junction (CEJ) with denudation 
of the root surface. Gingival recession occurs because 
of anatomical, pathological, and traumatic factors.1
Numerous periodontal plastic surgery techniques 
have been suggested for treating GRs.2 The connective 
tissue graft (CTG) with coronally advanced flap (CAF) 
procedure is the accepted gold standard for providing 
root coverage (RC), obtaining keratinized tissue gain 
and achieving predictable treatment outcomes.2 
However, this technique has several disadvantages, 
including insufficient donor tissue thickness, additional 
risk due to the presence of a second surgical site, 
extension of surgical procedure time, presence of a 
palatal neurovascular bundle in the proximity of the 
premolar–molar area, and limited graft size from the 
donor site with multiple defects or large recession 
areas. Furthermore, increased bleeding and pain 
complaints have been observed postoperatively. 
Therefore, alternative methods are used to treat 
GRs.3,4
Platelet concentrates (PCs) are used in the field of 
periodontology to provide key cells and growth factors 
to advance healing and promote regeneration.5,6 
Platelet-rich fibrin (PRF) has shown to exhibit slow 
dissolution and a long-lasting fibrin network structure. 
This structure provides a matrix that contains high 
amounts of growth factors, thrombocytes, and 
leukocytes.7 Concentrated growth factor (CGF) is 
identified as a new approach to produce PRF or a next-
generation PC.8,9 When producing CGF, the rotational 
speed of the centrifuge machine varies between 2400 
and 3000 rpm.8 The variability of the rotation speed 
during centrifugation results in a fibrin matrix that 
is larger, more intensive, and includes more growth 
factors than PRF.8-11 Some studies have reported that 
CGF induces osteogenic differentiation in periodontal 
ligament stem cells9 and new bone formation for sinus 
augmentation,10 results in a defect fill that was found 
to be similar to collagen membranes in the surgical 
treatment of peri-implantitis,12 and has chemical and 
mechanical properties similar to those of advanced 
PRF (A-PRF).13 In the literature, only one clinical study 
has examined the treatment of multiple GRs with CGF. 
That study showed CGF with CAF surgery increased 
the keratinized tissue width (KTW) and keratinized 
tissue thickness (KTT) and may prevent postoperative 
relapse after the CAF procedure.14 No studies were 
conducted comparing CGF with CTG regarding clinical 
or patient-related parameters.
Therefore, this clinical study sought to evaluate 
the clinical efficacy of CGF combined with CAF in the 
treatment of GR and to compare their effectiveness 
with CTG. It also sought to assess and compare 
postoperative pain and soft tissue healing.
Methodology
Study population and design
This split-mouth, randomized, controlled 
clinical study protocol was approved by the Ankara 
University Faculty of Dentistry Clinical Research 
Ethics Committee, Ankara, Turkey (B.30.2.A
NK.0.21.63.00/824-02/9-8/27;13/2, Clinical Trial.org-
NCT03020732). Written consent was obtained from all 
patients before administration of treatment. A total of 
19 patients were enrolled in this clinical trial. All were 
patients of the Gazi University Faculty of Dentistry, 
Department of Periodontology, and had aesthetic 
issues or cold/heat sensitivity problems associated 
with gingival recession; moreover, they all matched 
the features included in the criteria. This study was 
conducted from February 2013 to February 2014.
The inclusion criteria were: (1) at least 18 years 
of age; (2) systemically and periodontally healthy 
nonsmoker patients; (3) multiple adjacent or isolated 
Miller Class I GRs; (4) recession depth (RD) ≥2 
mm, probing depth (PD) ≤3 mm, located on lateral, 
canine, or premolars on the same arch (maxilla or 
mandible); (5) identifiable CEJ; (6) absence of caries 
or restoration on the buccal surface and no previous 
history of endodontic problems or treatment; and (7) 
palatal donor tissue thickness ≥3 mm for CTG.
The exclusion criteria were: (1) patients having 
a smoking habit or systemic diseases that might 
contraindicate periodontal surgery; (2) use of 
medication affecting the blood clotting mechanism and 
wound healing; (3) previous periodontal surgeries in GR 
areas; (4) pregnancy, lactation, or oral contraceptive 
drug use for female patients; and (5) insufficient oral 
hygiene (full-mouth plaque and bleeding scores ≥15% 
after phase I periodontal treatment) or unchanged 
traumatic tooth-brushing habit.
All participants received phase I periodontal 
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treatment one month before periodontal surgeries. 
Moreover, all participants underwent oral hygiene 
education and learned a non-traumatic tooth-brushing 
technique (the Roll technique) with an ultra-soft 
toothbrush as well as the use of dental floss or 
interdental brush for interproximal areas. Patients had 
either CAF with CGF (test) or CAF with CTG (control) 
surgeries on isolated (24 teeth on 9 maxillae and 3 
mandibles) or multiple adjacent defects (50 teeth on 
5 maxillae and 6 mandibles). A split-mouth design 
was used.
Clinical measurements
All clinical measurements were performed by the 
same investigator (S. K. A.). A calibration protocol 
was applied to ensure the reliability of measurements. 
Five patients and 15 GRs were assessed regarding the 
KTW, KTT, PD, clinical attachment level (CAL), and RD 
parameters twice within 72 hours. Calibration was 
accepted when measurements were similar at the 
90% level.15 Custom acrylic guides were prepared 
on patients’ plaster models for the standardization 
measurement. A periodontal probe (Nordent 
Manufacturing, Elk Grove Village, IL) was used to 
create mesio-buccal, mid-buccal, and disto-buccal 
reference notches on stents to obtain clinical data.
Plaque index (PI) and gingival index (GI) were 
recorded regarding the mean mesial, distal, and 
mid-facial surface measurement of a tooth.16 A 
periodontal probe was used at the mid-facial surface 
to obtain PD, CAL, RD, and KTW measurements; these 
measurements were rounded to the nearest millimeter. 
KTW was the distance from the free gingival margin to 
the mucogingival junction (MGJ), PD was the distance 
from the gingival margin to the bottom of the gingival 
crevice, and RD was the distance from the CEJ to the 
gingival margin. CAL was the distance from CEJ to the 
bottom of the gingival crevice. Recession width (RW) 
was measured as the horizontal distance between 
the mesial and distal recession borders coronally 
and parallel to the CEJ. The KTT value was obtained 
from a digital caliper (Stainless steel digital caliper, 
150 mm, Insize, China) with an accuracy of 0.01 mm 
using a size 15 endodontic reamer on the mid-point 
localization of keratinized tissue at the level bottom 
of the gingival crevice.15 RC was estimated using a 
formula.17 All measurements were recorded at the 
baseline and repeated at three months and six months. 
Wound healing was scored clinically at two and three 
weeks according to a healing index (HI), when tissue 
color, bleeding at palpation, epithelization of incision 
margins, and presence of suppuration and granulation 
tissue were also evaluated. A score of 1 indicated 
very poor improvement and 5 indicated excellent 
recovery.18,19 The HI at 1 week postoperatively was 
not performed due to the removal of the periodontal 
dressing on the 14th day after suture extraction. The 
Visual Analog Scale (VAS) with 100 mm was used 
to determine the patients’ postoperative pain level 
for the first seven days.20 No pain was indicated as 
0, and unbearable pain was indicated as 100. The 
patients received detailed information about the pain 
scale, and pain assessment was performed by the 
patients as self-reported. The patients were seen 
postoperatively on day 3 for the early recovery control, 
on day 7 for the delivery of the VAS scales and control 
of the periodontal dressing, on days 14 and 21 for the 
evaluation of HI, and in the first month for clinical 
measurements. Furthermore, additional appointments 
were scheduled at the third and sixth months.
CGF preparation
Immediately before the surgery test site, 
intravenous blood was drawn into two tubes without 
anticoagulant (Vacuette tubes, Greiner Bio-One North 
America Inc., USA). The blood was then centrifuged 
with a special centrifuge machine (Medifuge, Silfradent 
S.r.l., Sofia, Italy).8 The CGF was removed from the 
tube and separated from the red blood cell layer with 
a scissor; a special compressor was then used to 
obtain a CGF membrane of about 1 mm in thickness, 
as shown in Figure 1. Two CGF membranes were 
immediately placed into the recession area above the 
CEJ, in opposite directions.
Surgical procedures
All surgical procedures were performed in two 
separate sessions, one month apart, by the same 
surgeon (S. K. A.). Randomization was ensured with 
a coin toss by the same expert periodontist (B. Ü.) 
before the first surgeries. Local infiltration anesthesia 
(Ultracain D-S forte, Hoechst, Roussel, Frankfurt, 
Germany) was applied to the donor and the recipient 
sites. The technique, introduced by Langer and 
Langer21 (1985), was similarly administered to prepare 
recipient sites. A 15-C blade (Swann-Morton Ltd., 
Sheffield, England) was used for incisions and sharp 
dissection, and all muscle attachments were removed 
apically from the MGJ. After papillae de-epithelization, 
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either CTG or CGF was placed over the exposed 
root surface and fixed using suspension and simple, 
resorbable 5.0 sutures (Pegelak, Doğsan, İstanbul, 
Turkey). The flap was advanced 1 mm coronally from 
the CEJ to completely cover the CGF or CTG and was 
sutured with non-resorbable monofilament 5.0 sutures 
(Polyamid sutures, Seralon, Seragwiessner KG, Naila, 
Germany). This protocol was applied to both the test 
and the control groups, as shown in Figures 2 and 3.
CTG was taken from the area between the palatal 
canine teeth and the first molar teeth with a trapdoor 
technique. The graft horizontal and vertical sizes were 
adjusted to cover the open root surface and exceed 
2 mm of adjacent bone margins. The graft thickness 
was adjusted between 1.5 and 2 mm, as shown in 
Figure 4C. The cover was placed back in position and 
fixed with silk 3-0 simple sutures (Doğsan, İstanbul, 
Turkey), as shown in Figures 2 and 3.
Postoperative care
A periodontal dressing (Peripac, Dentsplay De Trey 
GmbH, Germany) on sterile aluminum foil was placed 
over the recipient area for both groups. The application 
of a cold compress extra-orally was recommended 
for the first 24 hours postoperatively, along with a 
soft-food diet and protection from trauma to surgical 
sites. Sutures were removed 14 days later, following 
which plaque control was achieved using an ultrasoft-
bristle brush at the surgical areas. All patients were 
prescribed a nonsteroidal anti-inflammatory drug 
(Flurbiprofen, Majezik SR 200 mg, Sanovel, İstanbul, 
Turkey) for pain control, twice a day for five days, and 
a 0.12% chlorhexidine gluconate (Klorhex, Drogsan 
Pharmaceuticals, Ankara, Turkey) mouth rinse 
twice a day for two weeks. Antibiotics [amoxicillin 
with clavulanic acid (Augmentin) BID 1000 mg, 
GlaxoSmithKline] were also given twice a day for five 
days as a precaution against the risk of postoperative 
infection.
Statistical analysis
The accepted sample size was 22 teeth for each 
group with a statistical power of 80%, according to the 
power analysis of other studies.22 A total of 37 teeth 
were included in each group as a precaution against 
possible loss. In this study, the SPSS for Windows, 
version 22.0, (SPSS Inc., Chicago, IL, USA) was used 
for data analysis. The normality of the quantitative 
Figure 1- Concentrated growth factor (CGF). (a) Clots form and centrifuge tubes. (b) A special compressor. (c) CGF membranes
Figure 2- Test group. (a) Preoperative view. (b) Flap design and vertical incisions. (c) CGF placement. (d) CAF and sutures. (e) First, third 
and sixth months postoperative view. CGF. concentrated growth factor; CAF. coronally advanced flap
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variables was investigated using the Kolmogorov–
Smirnov test. Descriptive statistics such as mean 
± standard deviation or median for continuous and 
discrete numeric variables (minimum–maximum) and 
demographic variables were shown for the number 
of cases and percentages. The Mann-Whitney U test 
was used for the intergroup evaluations. The Wilcoxon 
signed-rank test was used to assess changes in the 
double measurements, and the Friedman test was 
used to assess changes in the triple measurements 
(intragroup comparisons). The accepted significance 
levels were p<0.01 and p<0.05 for the results. 
The primary outcome variable was the evaluation 
of median RC. The secondary clinical measurements 
were the PI, GI, PD, RD, RW, CAL, KTT, KTW, HI, and 
VAS pain scores.
Results
A total of 74 Miller Class I GRs (24 isolated and 
50 multiple defects) in 23 jaws (14 maxillae and 9 
mandibles) of 19 patients (11 men and 8 women) were 
included in the study. The patients ranged in age from 
20 to 63. All the participants completed the follow-
up period of six months. In the maxillae, 38 GRs (22 
premolars and 16 canines) and in the mandible, 36 
GRs (22 premolars, 12 canines, and 2 lateral teeth) 
were treated. Two patients had multiple bilateral GRs 
in the maxilla and mandible. 
The PI, GI, and PD median values were not 
significantly different in the intergroup and intragroup 
comparisons (p>0.05; Table 1). The CAL median 
values significantly decreased in both study groups at 
the third and sixth months when compared with the 
baseline (p<0.05; Table 1), and the control group had 
higher baseline CAL median values than the test group. 
The CAL values did not differ significantly between the 
groups (p>0.05; Table 1).
Regarding KTW and KTT, significant increases in the 
CTG group were observed between the baseline and 
other follow-up times (p<0.05; Table 1). The changes 
in the CGF group were statistically significant only for 
KTT; no significant difference was found for KTW. In 
the intergroup comparisons, statistically significant 
differences were observed at the third and sixth 
months in favor of the control group (p<0.05; Table 2).
The median RD and RW values decreased 
significantly between the baseline and other follow-
up periods for both groups (p<0.05; Table 1), but 
Figure 3- Control group. (a) Preoperative view. (b) Flap design and vertical incisions. (c) Palatinal area. (d) CTG placement. (e) CAF and 
sutures. (f) First, third and sixth months postoperative view. CTG. connective tissue graft; CAF. coronally advanced flap
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they were not significantly different in the intergroup 
comparisons (p>0.05; Table 2). The CTG group had 
higher median RC values than the CGF group for all 
follow-up periods (p<0.05; Table 2). The increase 
Variable Time Control group(n=37) Test group(n=37)
Mean±SD Median-range Mean±SD Median-range Pa
 PI 
Baseline 0.02±0.07 0-0 (0) 0.03±0.09 0-0 (0) 0.623
3 months 0.04±0.15 0-1 (0) 0.0±0.00 0-0 (0) 0.16
6 months 0.03±0.09 0-0 (0) 0.08±0.18 0-1 (0) 0.889
Pb 0.819 0.223
GI 
Baseline 0.07±0.20 0-1 (0) 0.06±0.12 0-0 (0) 0.79
3 months 0.06±0.21 0-1 (0) 0.03±0.16 0-1 (0) 0.334
6 months 0.04±0.13 0-1 (0) 0.07±0.19 0-1 (0) 0.643
Pb 0.741 0.122
PD 
Baseline 1.43±0.55 1-3 (1) 1.39±0.54 1-3 (1) 0.711
3 months 1.38±0.49 1-2 (1) 1.42±0.50 1-2 (1) 0.74
6 months 1.46±0.55 1-3 (1) 1.36±0.54 1-3 (1) 0.406
Pb 0.803 0.584
CAL
Baseline 4.27±0.83 3-6 (4) 3.86±0.76 3-5 (4)     0.045*
3 months 2.62±1.21 1-5 (3) 2.78±1.22 1-6 (2.50) 0.723
6 months 2.54±1.01 1-5 (2) 2.56±1.08 1-5 (2) 0.963
Pb 0.001** 0.001**
Table 1- Evaluation of PI, GI, PD and CAL clinical parameters and comparisons
aMann Whitney U Test, statistically different between groups (*p<0.05).
bFriedman Test, significantly different compared with baseline (p<0.05, **p<0.01).
Variable Time Control group(n=37) Test group(n=37)
Mean±SD Median-range Mean±SD Median-range Pa
RD 
Baseline 2.97±0.92 2-5 (3) 2.47±0.69 2-4 (2)   0.012*
3 months 1.00±0.78 0-3 (1) 1.42±1.07 0-4 (1) 0.126
6  months 0.92±0.82 0-3 (1) 1.22±0.92 1-2 (1) 0.139
Pb 0.001** 0.001**
RW 
Baseline 3.54±0.65 2-5 (4) 3.39±0.76 2-5 (3) 0.304
3 months 2.30±1.63 0-5 (3) 2.67±1.35 0-5 (3) 0.359
6  months 2.16±1.67 0-5 (3) 2.44±1.36 0-5 (3) 0.565
Pb 0.001** 0.001**
KTW
Baseline 2.59±1.14 1-7 (2) 2.89±1.03 2-7 (3) 0.171
3 months 3.49±1.07 2-8 (3) 2.92±1.02 2-7 (3) 0.004**
6  months 3.57±1.14 2-8 (3) 3.03±1.02 2-7 (3) 0.019*
Pb 0.001** 0.291
KTT
Baseline 1.09±0.28 1-2 (1.06) 1.10±0.31 1-2 (1) 0.608
3 months 1.69±0.30 1-2 (1.70) 1.43±0.32 1-2 (1.40) 0.001**
6  months 1.63±0.31 1-2 (1.55) 1.38±0.34 1-2 (1.27) 0.001**
Pb 0.001** 0.001**
RC
3 months 66.60±26.29 0-100 (66.60) 50.45±28.79 0-100 (50) 0.015*
6  months 72.45±22.92 33-100 (66.60) 52.54±33.97 0-100 (50) 0.006**
Pc 0.038* 0.566
Table 2- Evaluation of RD, RW, KTW, KTT and RC clinical parameters and comparisons
aMann Whitney U Test, statistically different between groups (**p<0.01, *p<0.05).
bFriedman Test, significantly different compared with baseline (**p<0.01).
cWilcoxon Signed Rank Test, significantly different compared with baseline (*p<0.05).
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in RC in the sixth month when compared with the 
third month was significant only in the control group 
(p<0.05; Table 2).
The median HI values significantly increased 
in both groups in the third week when compared 
with the second week (p<0.05; Table 3). In the 
intergroup comparisons, the median HI values were 
similar between the groups; without differences 
(p<0.05; Table 3). In the intragroup comparisons, 
the increase in the VAS median values seen in the 
following days was statistically significant in both 
groups when compared with the baseline (p<0.05; 
Table 3). The VAS median values of days 2, 4, 5, and 
7 were significantly higher after CTG than after CGF 
(p<0.01; Table 3). No difference was observed for 
the other days.
A separate statistical evaluation was performed for 
the analysis of the difference in HI and VAS median 
values between the sites of isolated and multiple GRs, 
which were evaluated together in the test and control 
groups. According to this analysis, no significant 
difference was observed between the sites of isolated 
and multiple GRs in the test and control groups. 
Discussion
The effect of PC on the results of root coverage 
surgeries varies in the literature. The first reviews 
reported that PC treatments did not improve treatment 
results regarding RC, KTW, or CAL23, although 
recent reviews24 have reported that PRF reduces PD, 
attachment gain, RD, and patient morbidity. Recently, 
the changes in the centrifugation systems used for PC 
and the acquisition protocols have been believed to 
possibly change the properties of the fibrin structure 
and affect the clinical results.25 These new biomaterials 
are as follows: titanium-prepared PRF (T-PRF)26, 
A-PRF25, A-PRF+25, and CGF8. However, there are 
still too few clinical studies on the next generation of 
PRF-associated biomaterials in the literature. In this 
study, the CGF+CAF procedure was compared with 
CTG+CAF at the six-month follow-up. This is the first 
comparison in the literature.
The mean RC values for the CTG and CGF 
procedures were 72.45% and 52.45%, respectively. 
The CTG with CAF group was superior to the CGF 
with CAF group in terms of RC, KTT, and KTW. The 
treatment for the CGF with CAF group was found to 
be more effective only to reduce postoperative pain.
There are differing opinions as to whether 
techniques without vertical incisions provide better 
vascular support and healing27, aesthetic results28, 
positive effects on RC, and keratinized tissue gain20, or 
that vertical incision techniques provide better surgical 
vision, reduce flap tension29, shorten the operation 
time30 and provide RC.31 In this study, a technique 
with vertical incisions was preferred to provide better 
visibility and tension-free advancement of the flap for 
primary closure of the defect, CGF, and CTG.
CGF was first used by Doğan, et al.14 (2015) in 
the treatment of multiple gingival recessions in the 
maxilla. They reported that mean RC was 86.67% for 
Variable Time Control group(n=37) Test group(n=37)
Mean±SD Median-range Mean±SD Median-range Pa
VAS
Day 1 50.0±30.47 8-100 (45) 35.65±33.07 0-100 (24) 0.095
Day 2 29.61±31.26 0-100 (20) 16.04±25.27 0-100 (4) 0.031*
Day 3 19.74±29.35 0-100 (12) 10.78±24.52 0-100 (0) 0.065
Day 4 22.65±30.75 0-100 (13) 4.57±12.72 0-56 (0) 0.005**
Day 5 15.3±21.01 0-66 (0) 5.43±14.44 0-56 (0) 0.033*
Day 6 11±21.31 0-65 (0) 4.91±13.61 0-50 (0) 0.166
Day 7 11.09±19.07 0-60 (0) 3.61±12.84 0-57 (0) 0.041*
Pb 0.001** 0.001** Pc
HI
Week 2 3.86±0.69 3-5 (4) 3.78±0.73 2-5 (4) 0.779
Week 3 4.34±0.71 3-5 (4) 4.26±0.61 3-5 (4) 0.56
Pd 0.002** 0.002**
Table 3- Postoperative pain and healing evaluations
aMann Whitney U Test, statistically different between groups (**p<0.01, *p<0.05).
bFriedman Test, significantly different compared with baseline (**p<0.01).
cMann Whitney U Test, statistically different between groups (p<0.05).
dWilcoxon Signed Rank Test, significantly different compared with baseline (**p<0.01).
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the CAF (modified) with CGF group after six months. 
Doğan, et al.14 (2015) reported that CGF treatment 
did not show any additive effect on the RC results 
of the CAF procedure. The authors14 suggested CGF 
application with CAF might increase the long-term 
stability of RC due to increasing KTW (0.58 mm) and 
KTT (0.32 mm), which caused a better attachment 
gain. Increases of 0.14 mm/0.28 mm, respectively, 
were observed in the KTW/KTT at the sixth month for 
the CGF group. Some results of this study showed 
increased KTT and attachment gains, which agrees 
with Doğan, et al.14 (2015). However, CGF had no 
effect on KTW and showed a lower RC percentage. The 
differences observed are possibly due to differences in 
the surgical and study designs. Unlike Doğan, et al.14 
(2015), molar teeth were excluded in the study due 
to the RW values, larger surgical field, and complex 
anatomy. Another difference was that it included 
defects in both maxilla and mandible. Muscles in the 
maxilla and mandible have been reported to have 
different tensile strength and that differences in flap 
thicknesses in the jaws may produce different results 
on RC.32 This can be considered a limitation of this 
study.
In the literature, there are differences between 
the studies conducted with innovative PRF protocols 
and conventional methods, especially regarding the 
RC, KTT, and KTW results. PRF was suggested as an 
alternative to CTG for multiple and isolated GR.3,22,32,33 
Uraz, et al.32 (2015) reported RC values as 95% and 
96.1% after six months, and Tunalı, et al.22 (2015) 
as 76.63% and 77.3% after 12 months (22) for the 
PRF and CTG groups, respectively. PRF was superior 
regarding the increased KTT15,29,33 and postoperative 
patient comfort,29,33 whereas a higher KTW was 
reported for CTG33 in multiple GRs. The mean RC for 
T-PRF and CTG treatments were reported as 91.06% 
and 92.04%, respectively, at the sixth month, without 
difference between the groups.27 T-PRF was reported 
as superior in terms of the resulting KTW, whereas 
CTG was found to be better than T-PRF for KTT in 
a recent study.27 In this study, CGF did not seem to 
have improved clinical outcomes when compared 
with CTG. Although CGF membranes and others form 
a vital cell trap, their resorption times and stability 
may not be sufficient for the cells to repopulate in 
the region.12 In addition to clinical trial design and 
methodology differences in studies, the differences 
in centrifugation25 and the tube from which blood is 
collected27 may have affected clinical outcomes.6
Studies have suggested that PRF treatment 
increases KTW due to the release of growth factors 
involved in the stimulation and proliferation of 
gingival and periodontal fibroblasts.3,4,18 CTG includes 
connective tissue, which has the ability to induce 
keratinizing epithelium as a result of an increase in 
KTW.3,4,18 Autogenous biomaterials are suggested to 
have functioned as gap fillers for an increase in KTT 
by increasing the tissue thickness such that it shows 
a histoconductive effect.27 Moreover, the increase in 
KTT is thought to be influenced by the initial flap/
graft thickness and incisions.3,27,33 In this study, initial 
KTT and KTW values were similar. CTG thickness 
was applied at a thickness of 1.5–2 mm and CGF 
membranes were applied in 2 layers with an average 
thickness of 2 mm to eradicate a negative effect.
Culhaoglu, et al.34 (2018) reported they achieved 
a higher RC percentage when they compared a two-
fold application of PRF with a four-fold application. 
RC values were 69.65% and 56.34% for 4PRF with 
CAF and 2PRF with CAF, respectively, at the sixth 
month.34 PRF was suggested to be administered as 
multilayered as possible.34 Similarly, in this study, 
a four-fold application of CGF could provide higher 
RC values. Another view is that placement of these 
autogenous biomaterials under the flap may limit the 
collateral circulation required for revascularization and 
healing.3,33 Comparative studies are needed to clarify 
the dose-dependent effect of PCs. Culhaoglu, et al.34 
(2018) described the RD changes in the control group 
as “creeping attachment,” while the changes in the 
test group explained the degree of resorption in the 
membrane and the apical migration of flap.34-36 In this 
study, the control group had higher RD values at the 
baseline than the test group; however, no difference 
was observed at the sixth month. The higher RC 
values in the control group can be explained by the 
KTW increase and creeping attachment, in addition to 
the higher initial RD values. There was a significant 
decrease in CAL in both groups. Since the histological 
analysis was not performed, the type of attachment 
was not known.
PRF has been suggested to accelerate soft tissue 
healing with growth factors in addition to the fibrin 
network structure.7,18,19 Several studies have reported 
that PRF application decreases postoperative pain for 
the first seven days and accelerates healing during 
the first, second, and third weeks when compared 
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with CTG or Emdogain.18,19 In this study, the median 
HI values were not different between test and control 
groups. Additionally, the CTG group had significantly 
greater VAS values than the CGF group. Postoperative 
discomfort and pain after CTG surgery are common, 
especially in the first week.2 Absence of donor site15 
and reduction in operation time33 have been described 
to decrease the pain reported by the patient. The 
coexistence of single and multiple defects may 
have also affected the healing and pain evaluations. 
However, no difference was observed between these 
two groups according to the separate analysis for 
single and multiple defects.
Studies have reported that CTG size and thickness 
and their position in CEJ may negatively affect graft 
vascularization, flap dehiscence, RC, postoperative 
comfort, and aesthetics.37,38 Thinner, shorter grafts 
might provide better vascular nutrition from the 
flap covering the graft and connective tissue of the 
donor bed and might also improve postoperative 
comfort with aesthetic results.37,38 In this study, the 
CTG was standardized to be 1.5–2 mm thick, and 
the graft horizontal and vertical dimensions were 
adjusted to exceed 2 mm of the exposed root surface. 
Despite the attempt to establish a similar recipient 
bed environment, differences in recipient bed width 
and graft sizes for isolated and multiple GRs may 
be considered limitations for RC, healing, and pain 
assessments. 
This study had a split-mouth design with both single 
and multiple defects. Split-mouth design was more 
objective than parallel design for clinical studies.3,17 In 
our view, researchers may find it difficult to provide 
the number of patients with both test and control 
defects required for statistical power of research in a 
split-mouth design. Regarding the power of this study, 
no grouping (isolated/multiple) was performed but 
the number of defects was analyzed. In the literature, 
studies generally show the results of isolated and 
multiple defects separately. Factors that are effective 
in this respect include defect, recipient bed and graft 
width changes, and differences in vascularization and 
wound healing, as well as clinical parameters such as 
pain reported by the patient.38-40 The defect-related 
features such as RW, KTW, KTT, and the teeth were 
determined to be symmetrical in the same jaw for 
the test and control groups in each patient, and the 
negative effects of the study were reduced as much 
as possible. 
Conclusion
Within the limits of this 6-month follow-up study, 
CGF did not improve clinical outcomes, especially 
primary-outcome RC when compared with CTG. 
This method had a more positive effect only on 
postoperative pain. This finding is not enough to show 
the correct clinical effect of CGF against CTG with 
CAF, considering the defect characteristics and jaw 
differences in this study. Future studies should have 
higher standardization with large patient populations, 
and comparisons with other next-generation PCs, 
in which single and multiple defects are separately 
analyzed.
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